ATE21119T1 - Verfahren zur herstellung von 3-oxo-delta-1,4steroiden. - Google Patents

Verfahren zur herstellung von 3-oxo-delta-1,4steroiden.

Info

Publication number
ATE21119T1
ATE21119T1 AT81110184T AT81110184T ATE21119T1 AT E21119 T1 ATE21119 T1 AT E21119T1 AT 81110184 T AT81110184 T AT 81110184T AT 81110184 T AT81110184 T AT 81110184T AT E21119 T1 ATE21119 T1 AT E21119T1
Authority
AT
Austria
Prior art keywords
oxo
delta
4steroids
preparation
steroid
Prior art date
Application number
AT81110184T
Other languages
English (en)
Inventor
Alfred Dr Weber
Mario Dr Kennecke
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of ATE21119T1 publication Critical patent/ATE21119T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/02—Dehydrogenating; Dehydroxylating
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0084—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Radio Relay Systems (AREA)
  • Mobile Radio Communication Systems (AREA)
AT81110184T 1980-12-23 1981-12-05 Verfahren zur herstellung von 3-oxo-delta-1,4steroiden. ATE21119T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3049399 1980-12-23
EP81110184A EP0054810B1 (de) 1980-12-23 1981-12-05 Verfahren zur Herstellung von 3-Oxo-delta-1,4-steroiden

Publications (1)

Publication Number Publication Date
ATE21119T1 true ATE21119T1 (de) 1986-08-15

Family

ID=6120490

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81110184T ATE21119T1 (de) 1980-12-23 1981-12-05 Verfahren zur herstellung von 3-oxo-delta-1,4steroiden.

Country Status (10)

Country Link
US (1) US4839282A (de)
EP (1) EP0054810B1 (de)
JP (1) JPS57170196A (de)
AT (1) ATE21119T1 (de)
DD (1) DD202049A5 (de)
DE (1) DE3175049D1 (de)
DK (1) DK572181A (de)
FI (1) FI72744C (de)
HU (1) HU187390B (de)
RO (1) RO83629B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192755A (en) * 1986-01-15 1993-03-09 Akzo N.V. Pregnane derivatives as immunomodulators
JPH04256202A (ja) * 1991-02-08 1992-09-10 Nec Corp ダイオード移相器
AU5873300A (en) * 1999-07-07 2001-01-30 Pharmacia & Upjohn Company Process to prepare exemestane
EP1399463A1 (de) * 2001-06-18 2004-03-24 PHARMACIA & UPJOHN COMPANY Verfahren zum herstellung vom 11beta, 17alpha, 21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione-acetate
EP1359154A1 (de) * 2002-04-29 2003-11-05 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Weitere Verfahren zur Herstellung von Cyproteron Azetat
RU2480475C1 (ru) * 2011-11-16 2013-04-27 Российская Федерация, От Имени Которой Выступает Министерство Промышленности И Торговли Российской Федерации Микробиологический способ получения 21-ацетоксипрегна-1,4,9( 11 ),16-тетраен-3,20-диона из 21-ацетоксипрегна-4,9( 11 ),16-триен-3,20-диона
CN106699830A (zh) * 2016-11-20 2017-05-24 中国石油大学(华东) 一种16‑β甲基孕甾烯甾体激素中间体及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1070176B (de) * 1959-12-03 American Cyanamid Company, New York, N. Y. (V. St. A.) Verfahren zur Herstellung neuer Steroidverbindungen der 1, 4 - Pregnadienreihe
DE1093792B (de) * 1957-11-27 1960-12-01 Pfizer & Co C Verfahren zur Herstellung von 3-Keto-í¸-steroiden
DE1107225B (de) * 1959-08-05 1961-05-25 Hoechst Ag Verfahren zur Herstellung von 1, 4, 17(20)-Pregnatrienen
GB1092145A (en) * 1964-06-02 1967-11-22 Noda Inst For Scientific Res Microbiological conversion of steroids
US4101378A (en) * 1975-06-06 1978-07-18 Mitsubishi Chemical Industries Limited Process for the microbiological oxidation of steroids
EP0055832B1 (de) * 1980-12-23 1986-02-26 Schering Aktiengesellschaft Verfahren zur Herstellung von 11-beta,21-Dihydroxy-2'-methyl-5'-beta-H-1,4-pregnadien-(16,17)-oxazol-3,20-dion

Also Published As

Publication number Publication date
RO83629A (ro) 1984-06-21
DD202049A5 (de) 1983-08-24
FI72744B (fi) 1987-03-31
EP0054810A3 (en) 1983-09-28
DK572181A (da) 1982-06-24
US4839282A (en) 1989-06-13
JPH0260319B2 (de) 1990-12-14
FI72744C (fi) 1987-07-10
HU187390B (en) 1985-12-28
JPS57170196A (en) 1982-10-20
DE3175049D1 (en) 1986-09-04
EP0054810B1 (de) 1986-07-30
FI814128L (fi) 1982-06-24
EP0054810A2 (de) 1982-06-30
RO83629B (ro) 1984-08-30

Similar Documents

Publication Publication Date Title
ATA290981A (de) Verfahren zur herstellung von mikroorganismen
AT380694B (de) Verfahren zur herstellung von mikroorganismen
YU45871B (sh) Polipeptid sa humanim imunointerferonskim (ifn-gama) svojstvima
AT368548B (de) Verfahren zur herstellung von hybrid-bakterien
ATE14597T1 (de) Verfahren zur enzymatischen herstellung von l-2- amino-4-methylphosphinobuttersaeure.
ATE5726T1 (de) Verfahren zur herstellung von antibiotikum c15003 p3.
ATE21119T1 (de) Verfahren zur herstellung von 3-oxo-delta-1,4steroiden.
ATE7309T1 (de) Verfahren zur herstellung von d-n-carbamoyl-alpha-aminosaeuren und mikroorganismen dafuer.
ATE2T1 (de) Verfahren zur herstellung von cis-2,6dimethylmorpholin
ATE81341T1 (de) Verfahren zur herstellung von antibiotica 10381b.
DE3673054D1 (de) Kontinuierliches verfahren zur herstellung von ethanol durch bakterielle fermentation.
ATE18257T1 (de) Verfahren zur herstellung von 11-beta,21dihydroxy-2'-methyl-5'-beta-h-1,4-pregnadien(16,17)-oxazol-3,20-dion.
AT374494B (de) Verfahren zur anreicherung von mikroorganismenbiomasse
EP0291696A3 (de) Verfahren zur Vermehrung von Epithelialzellen
ATE43342T1 (de) Verfahren zur herstellung von hydrogeno- oder halogenosilanen.
ATE11568T1 (de) Verfahren zur herstellung von 11-alpha-hydroxy-20-alpha-hydroxymethyl-1,4-pre nadien-3-on.
IT8121234A0 (it) Processo per la produzione di l-alanina usando microorganismi immobilizzati.
ATE3991T1 (de) Verfahren zur herstellung von 9-alpha-hydroxy-4- androsten-3,17-dion.
DD138784A5 (de) Verfahren zur kontinuierlichen fermentation von mikroorganismen
ATE178093T1 (de) Verfahren zur herstellung von neuraminidase
DE59108700D1 (de) Verfahren zur herstellung von 17-oxosteroiden
ATE8504T1 (de) Verfahren zur herstellung von 5dimethylaminomethyl-2-furanmethanol.
ATE18256T1 (de) Antianaemische zusammensetzung und verfahren zu deren herstellung.
ATE71406T1 (de) Verfahren zur durchfuehrung enzymatischer oxidationen.
IT7850955A0 (it) Procedimento per la coltura aerobica di microorganismi

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee